User profiles for Hana Študentová

Hana Študentová

Associate professor
Verified email at fnol.cz
Cited by 755

[HTML][HTML] Neopterin as a biomarker of immune response in cancer patients

…, LK Krčmová, L Javorská, H Študentová - Annals of …, 2017 - ncbi.nlm.nih.gov
With the advent of immunotherapy the topic of biomarkers of immune response is of high
interest. Along with the expression of programmed death ligand 1 (PD-L1) or tumor infiltrating …

[HTML][HTML] Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls

…, K Hořejší, I Brabcová, D Vrána, H Študentová… - Scientific Reports, 2021 - nature.com
Early detection of cancer is one of the unmet needs in clinical medicine. Peripheral blood
analysis is a preferred method for efficient population screening, because blood collection is …

Determination of one year stability of lipid plasma profile and comparison of blood collection tubes using UHPSFC/MS and HILIC-UHPLC/MS

…, R Jirásko, O Peterka, V Mužáková, H Študentová… - Analytica Chimica …, 2020 - Elsevier
Abstract Effects of blood collection tubes, the time period, the sample origin, and the method
used on the lipidomic profile are investigated by ultrahigh-performance supercritical fluid …

Robust and high-throughput lipidomic quantitation of human blood samples using flow injection analysis with tandem mass spectrometry for clinical use

…, Z Vaňková, D Wolrab, R Hrstka, H Študentová… - Analytical and …, 2023 - Springer
Direct infusion of lipid extracts into the ion source of a mass spectrometer is a well-established
method for lipid analysis. In most cases, nanofluidic devices are used for sample …

[HTML][HTML] Altered plasma, urine, and tissue profiles of sulfatides and sphingomyelins in patients with renal cell carcinoma

…, A Kvasnička, D Friedecký, K Polański, H Študentová… - Cancers, 2022 - mdpi.com
Simple Summary Renal cell carcinoma (RCC) is among the most common cancer types in
both men and women, and its early detection significantly improves survival. Minimally-…

Intra-laboratory comparison of four analytical platforms for lipidomic quantitation using hydrophilic interaction liquid chromatography or supercritical fluid …

M Chocholoušková, D Wolrab, R Jirásko, H Študentová… - Talanta, 2021 - Elsevier
The lipidomic research is currently devoting considerable effort to the harmonization that
should enable the generation of comparable and accurate quantitative lipidomic data across …

Lenvatinib for the treatment of kidney cancer

H Študentová, D Vitásková… - Expert Review of …, 2018 - Taylor & Francis
Introduction: Sequential administration of single targeted agents has evolved as the dominant
paradigm in advanced RCC treatment. Lenvatinib plus everolimus is the first combination …

[HTML][HTML] Risk factors of atherosclerosis during systemic therapy targeting vascular endothelial growth factor

H Študentová, J Indráková, P Petrová… - Oncology …, 2016 - spandidos-publications.com
The aim of the present study was to examine the changes in intima‑media thickness (IMT) and
myocardial perfusion in association with other laboratory risk factors for atherosclerosis in …

Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma

…, B Melichar, D Vitásková, H Študentová - Future …, 2021 - Future Medicine
Sequential administration of single targeted agents has been challenged as the dominant
treatment paradigm in patients with metastatic renal cell carcinoma by improved outcomes …

Role of subcutaneous formulation of trastuzumab in the treatment of patients with HER2-positive breast cancer

B Melichar, H Študentová, H Kalábová… - Immunotherapy, 2014 - Future Medicine
Tumors in about 15% of patients with breast cancer overexpress HER2. Trastuzumab (Herceptin
® ; F. Hoffmann–La Roche, Basel, Switzerland) is a humanized monoclonal antibody …